Explain this page
Arphra AIPlain-English read on AbbVie Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$1,652.36
+662.76% vs spot
Recommendation
Strong Buy
15 of 17 methods
Method spread
5bull10bear
±5% threshold
Analyst PT consensus: $257.54 (+18.88%)
Candlestick · 1Y
Open in chart workstation →ABBV
216.49+16.83%H 244.81L 181.73MA50 211.54MA200 220.51Avg vol 6.2M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.08% | -4.78% | +1.34% | +5.04% | -4.49% | -5.19% | +16.91% | +57.18% | +88.82% | +260.39% | +518.94% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$34.15M
10 txns
Net flow
−$34.15M
Aftermarket
LiveLast trade
$216.98
Bid
$216.75
200 sh
Ask
$217.38
200 sh
Spread
$0.630
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $15B | $699M | $0.39 |
| Q4 Dec 2025 | $16.62B | $1.82B | $1.02 |
| Q3 Sep 2025 | $15.78B | $186M | $0.10 |
| Q2 Jun 2025 | $15.42B | $938M | $0.53 |
| Q1 Mar 2025 | $13.34B | $1.29B | $0.72 |
| Q4 Dec 2024 | $15.1B | -$22M | $-0.02 |
Sector & industry today
LiveSectors
- Technology+2.51%
- Communication Services+1.85%
- Utilities+1.35%
- Consumer Cyclical+0.30%
- Consumer Defensive-0.30%
- Energy-0.45%
- Industrials-0.48%
- Basic Materials-0.66%
- Financial Services-0.67%
- Real Estate-0.99%
- Healthcare-1.51%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General-1.90%
- Oil & Gas Energy+8.53%
- Business Equipment & Supplies+5.82%
- Semiconductors+5.24%
- Electronic Gaming & Multimedia+5.23%
- Advertising Agencies-5.20%
- Medical - Equipment & Services+5.08%
- Grocery Stores-4.35%
- Financial - Mortgages+4.08%
- Broadcasting+4.00%
- Computer Hardware-3.67%
- Internet Content & Information+3.58%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$257.54
+18.88% upside
Low
$223.00
Median
$260.00
High
$298.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- AbbVie nears $11 billion deal for Apogee Therapeutics, FT reportsreuters.com·Jun 19, 2026
- AbbVie: Immunology Cash Flow Funds Oncology Expansionseekingalpha.com·Jun 19, 2026
- AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Knowzacks.com·Jun 18, 2026
- AbbVie Declares Quarterly Dividendprnewswire.com·Jun 18, 2026
- AbbVie Declares Quarterly Dividendprnewswire.com·Jun 18, 2026
- 3 Dividend Stocks That Pay You More Every Single Year247wallst.com·Jun 17, 2026
- AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on Itzacks.com·Jun 17, 2026
- AbbVie: Maintaining My Strong Buy Rating After Label Expansionseekingalpha.com·Jun 16, 2026
Financial scores
DBJun 19, 2026Altman Z
2.58
Grey
≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress
Piotroski F
7/9
Strong
≥ 7 strong · 4–6 average · < 4 weak
Peers
Total assets
$133.96B
Total debt
$69.07B
Cash & equiv
$5.23B
Operating CF
$19.03B
Free cash flow
$17.82B
Buybacks
-$980M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Purdue David Ryan officer: SVP, Controller | Sell | 5,230 | $1.22M | Mar 04, 2026 |
Siatis Perry C officer: EVP, GC AND SECRETARY | Sell | 5,777 | $1.35M | Mar 02, 2026 |
Siatis Perry C officer: EVP, GC AND SECRETARY | Sell | 2,600 | $611.68K | Mar 02, 2026 |
Siatis Perry C officer: EVP, GC AND SECRETARY | Sell | 10,291 | $2.41M | Mar 02, 2026 |
Siatis Perry C officer: EVP, GC AND SECRETARY | Sell | 22,381 | $5.15M | Feb 25, 2026 |
SALEKI-GERHARDT AZITA officer: EVP, CHIEF OPERATIONS OFFICER | Sell | 42,370 | $8.41M | Aug 12, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $61.16B | $20.09B | $4.23B | $2.37 | +6.91% |
| FY 2024 | $56.33B | $9.14B | $4.28B | $2.39 | +7.59% |
| FY 2023 | $54.32B | $12.76B | $4.86B | $2.72 | +8.95% |
| FY 2022 | $58.05B | $18.12B | $11.84B | $6.63 | +20.39% |
| FY 2021 | $56.2B | $17.92B | $11.54B | $6.45 | +20.54% |